China NMPA Product Recall - Implantable cardiac pacemaker, implantable cardiac resynchronization pacemaker

St. Jude Medical Supplies (Shanghai) Co., Ltd. initiated a Class II voluntary recall for several models of its implantable pacemakers and implantable cardiac resynchronization pacemakers. This action, published by the National Medical Products Administration (NMPA) on October 11, 2017, addresses identified cybersecurity vulnerabilities within these critical medical devices. The company's main concern is to enhance product security and mitigate the risk of potential cybersecurity attacks that could affect device performance. The regulatory framework for this recall falls under the NMPA, previously known as the CFDA. Required actions by St. Jude Medical Supplies (Shanghai) Co., Ltd. include the voluntary recall of specific affected products, identified by their registration numbers such as CFDA (Imported) 20143214074. Concurrently, the company is committed to implementing additional security measures and updating existing protocols to bolster the devices against future cyber threats. This proactive step underscores the industry's focus on maintaining patient safety and device integrity in the face of evolving digital security challenges. Detailed information on affected models and batches is provided in the